Skip to main content
De novo design of Ras isoform selective binders.
Plasmodiumfalciparum protein kinase 6 and hemozoin formation are inhibited by a type II human kinase inhibitor exhibiting antimalarial activity.
Proteasome inhibitors: The next generation of antimalarial drugs?